TBE Zone 2 PMS in Japan
GORE® TAG® Thoracic Branch Endoprosthesis Zone 2 Post-Market Surveillance in Japan
W.L.Gore & Associates
200 participants
Dec 15, 2025
OBSERVATIONAL
Conditions
Summary
The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients who attempted implant of TBE in Zone 2 during the enrollment period of this surveillance.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07049913